Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J.C. Locklear

An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study

Value in Health

English

Related publications

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Multiple Sclerosis

Neurology

2011

English

Network Analysis of Transcriptional Regulation in Response to Intramuscular Interferon-Β-1a Multiple Sclerosis Treatment

Pharmacogenomics Journal

English

Subjective Patient-Reported Versus Objective Adherence to Subcutaneous Interferon Β-1a in Multiple Sclerosis Using RebiSmart®: The CORE Study

English

Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a

Journal of Negative Results in BioMedicine

English

Patient-Rated Suitability of a Novel Electronic Device for Self-Injection of Subcutaneous Interferon Beta-1a in Relapsing Multiple Sclerosis: An International, Single-Arm, Multicentre, Phase IIIb Study

English

Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings From the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis

English

Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

English

Daclizumab Is More Effective in Reducing Relapse Rates in Multiple Sclerosis Patients Than Interferon Beta-1a

Journal of pharmacology & clinical research

2017

English

Subcutaneous Interferon Β-1a in Pediatric Patients With Multiple Sclerosis: Regional Differences in Clinical Features, Disease Management, and Treatment Outcomes in an International Retrospective Study

Journal of the Neurological Sciences

Neurology

2016

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J.C. Locklear

An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study

Related publications

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Network Analysis of Transcriptional Regulation in Response to Intramuscular Interferon-Β-1a Multiple Sclerosis Treatment

Subjective Patient-Reported Versus Objective Adherence to Subcutaneous Interferon Β-1a in Multiple Sclerosis Using RebiSmart®: The CORE Study

Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a

Patient-Rated Suitability of a Novel Electronic Device for Self-Injection of Subcutaneous Interferon Beta-1a in Relapsing Multiple Sclerosis: An International, Single-Arm, Multicentre, Phase IIIb Study

Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings From the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis

Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

Daclizumab Is More Effective in Reducing Relapse Rates in Multiple Sclerosis Patients Than Interferon Beta-1a

Subcutaneous Interferon Β-1a in Pediatric Patients With Multiple Sclerosis: Regional Differences in Clinical Features, Disease Management, and Treatment Outcomes in an International Retrospective Study